---
title: "GKCT: Loss of 24.7334 million yuan in the first half of the year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254642589.md"
description: "On the evening of August 26, GKCT disclosed its 2025 semi-annual report, achieving an operating income of 328 million yuan in the first half of the year, a year-on-year increase of 45.92%; the net profit attributable to the parent company was -24.7334 million yuan; the basic earnings per share were -0.0589 yuan. The increase in operating income compared to the same period last year was mainly due to the rapid growth in sales revenue of Wi-Fi 7 products, demonstrating strong market competitiveness"
datetime: "2025-08-26T13:12:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254642589.md)
  - [en](https://longbridge.com/en/news/254642589.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254642589.md)
---

# GKCT: Loss of 24.7334 million yuan in the first half of the year

GKCT disclosed its 2025 semi-annual report on the evening of August 26, achieving an operating income of 328 million yuan in the first half of the year, a year-on-year increase of 45.92%; net profit attributable to the parent company was -24.7334 million yuan; basic earnings per share were -0.0589 yuan. The increase in operating income compared to the same period last year was mainly due to the rapid growth in sales revenue of Wi-Fi 7 products, demonstrating strong market competitiveness

### Related Stocks

- [688653.CN](https://longbridge.com/en/quote/688653.CN.md)

## Related News & Research

- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [Stocks to buy: Tata Communications, Nibe, ELGI Equipments on analyst radar](https://longbridge.com/en/news/287141880.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [20:38 ETHyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"](https://longbridge.com/en/news/287135394.md)